Open Account
Demo Account
About Us
Real-time Quotes & News
Market Analysis
Economic Calendar
Daily Market Analysis
Trading Platform
Platform Overview
How To Use
Terms
All Terms
Deposit & Withdrawal
Promotion
FAQ
Contact
繁
简
EN
User Login
Open Account
Demo Account
繁
简
EN
User Login
Open Account
Demo Account
About Us
About Aspire
Features of Aspire
Real-time Quotes & News
Real-time Quotes
Real-time News
Market Analysis
Economic Calendar
Market Analysis
Trading Platform
Meta Trader 5
Platform Features
Terms
All Terms
Deposit & Withdrawal
Promotion
FAQ
Contact
About Us
Terms
Metals Market
Trading Platform
Market Analysis
Promotion
FAQ
Contact
繁
简
EN
US crude futures maintained gains after the EIA crude inventory release.
2026-10-28
US crude futures maintained gains after the EIA crude inventory release.
Back
Other News
2026-10-28
As anticipation for Anthropic's IPO heats up, investors need to be wary of the dramatic volatility that can occur after a hot IPO. Historical statistics on large IPOs show that the average maximum drawdown of 20 large listed companies in their first
As anticipation for Anthropic's IPO heats up, investors need to be wary of the dramatic volatility that can occur after a hot IPO. Historical statistics on large IPOs show that the average maximum drawdown of 20 large listed companies in their first year was approximately 60%, meaning their share price fell by about 60% from its peak. Similar statistics, from Truist's analysis of 30 popular tech IPOs, found that their average maximum drawdown in the first year was 55%, with a median of 54%. This demonstrates that even with strong growth prospects, high valuations in the early stages of an IPO, shifts in market sentiment, and profit-taking by early investors can still lead to significant volatility. For a hot AI company like Anthropic, a high valuation is inevitable; however, for investors, the more important question is whether the IPO price has already factored in future growth, and specifically, how much future growth has been overdrawn.
2026-10-28
China A-share innovative drugs sector extended gains; Laimei Pharmaceutical and Baipusais hit limit-up, Nuosige and Haichuang Pharmaceutical rose over 10%, while Puruisi, Yinuosi, Hualan Co., Tebao Biotech and Hengrui Medicine also advanced.
China A-share innovative drugs sector extended gains; Laimei Pharmaceutical and Baipusais hit limit-up, Nuosige and Haichuang Pharmaceutical rose over 10%, while Puruisi, Yinuosi, Hualan Co., Tebao Biotech and Hengrui Medicine also advanced.
Chat with us
, powered by
LiveChat